3728 Jinke Rd, Bldg 1, West Wing, Shanghai, China info@tyligand.com
Chinese Version（中文版）

News & Release

Tyligand Bioscience Receives IND Clearance from China NMPA for TSN084, a Multi-kinase Inhibitor to Address Tumor Resistance to Targeted Therapies

Tyligand Bioscience and Context Therapeutics Sign Strategic Development Agreement for Onapristone ER

Tyligand Bioscience Aquired ONA-XR (Onapristone sustained relese) right of development and commercialization in Greater China

Tyligand Bioscience completed A round of financing